137 related articles for article (PubMed ID: 29848667)
1. Simvastatin interferes with cancer 'stem-cell' plasticity reducing metastasis in ovarian cancer.
Kato S; Liberona MF; Cerda-Infante J; Sánchez M; Henríquez J; Bizama C; Bravo ML; Gonzalez P; Gejman R; Brañes J; García K; Ibañez C; Owen GI; Roa JC; Montecinos V; Cuello MA
Endocr Relat Cancer; 2018 Oct; 25(10):821-836. PubMed ID: 29848667
[TBL] [Abstract][Full Text] [Related]
2. Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer.
Greenaway JB; Virtanen C; Osz K; Revay T; Hardy D; Shepherd T; DiMattia G; Petrik J
Oncotarget; 2016 Jul; 7(30):47343-47365. PubMed ID: 27329838
[TBL] [Abstract][Full Text] [Related]
3. Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo.
Pereira M; Glogova A; Haagsma J; Stewart J; Shepherd TG; Petrik J
J Ovarian Res; 2023 Nov; 16(1):218. PubMed ID: 37986175
[TBL] [Abstract][Full Text] [Related]
4. Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
Likus W; Siemianowicz K; Bieńk K; Pakuła M; Pathak H; Dutta C; Wang Q; Shojaei S; Assaraf YG; Ghavami S; Cieślar-Pobuda A; Łos MJ
Drug Resist Updat; 2016 Mar; 25():13-25. PubMed ID: 27155373
[TBL] [Abstract][Full Text] [Related]
5. The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer.
Stine JE; Guo H; Sheng X; Han X; Schointuch MN; Gilliam TP; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Jan; 7(1):946-60. PubMed ID: 26503475
[TBL] [Abstract][Full Text] [Related]
6. Statins affect cancer cell plasticity with distinct consequences for tumor progression and metastasis.
Dorsch M; Kowalczyk M; Planque M; Heilmann G; Urban S; Dujardin P; Forster J; Ueffing K; Nothdurft S; Oeck S; Paul A; Liffers ST; Kaschani F; Kaiser M; Schramm A; Siveke JT; Winslow MM; Fendt SM; Nalbant P; Grüner BM
Cell Rep; 2021 Nov; 37(8):110056. PubMed ID: 34818551
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin exhibits antiproliferative effects on spheres derived from canine mammary carcinoma cells.
Torres CG; Olivares A; Stoore C
Oncol Rep; 2015 May; 33(5):2235-44. PubMed ID: 25778435
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a.
Wolfe AR; Debeb BG; Lacerda L; Larson R; Bambhroliya A; Huang X; Bertucci F; Finetti P; Birnbaum D; Van Laere S; Diagaradjan P; Ruffell B; Trenton NJ; Chu K; Hittelman W; Diehl M; Levental I; Ueno NT; Woodward WA
Breast Cancer Res Treat; 2015 Dec; 154(3):495-508. PubMed ID: 26590814
[TBL] [Abstract][Full Text] [Related]
9. Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.
Pandian V; Ramraj S; Khan FH; Azim T; Aravindan N
Stem Cell Res Ther; 2015 Feb; 6(1):2. PubMed ID: 25888913
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells.
Yang T; Chen M; Sun T
Cell Physiol Biochem; 2013; 31(6):863-74. PubMed ID: 23817018
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin is effective in killing the radioresistant breast carcinoma cells.
Aschenbrenner B; Negro G; Savic D; Sorokin M; Buzdin A; Ganswindt U; Cemazar M; Sersa G; Skvortsov S; Skvortsova I
Radiol Oncol; 2021 May; 55(3):305-316. PubMed ID: 33939900
[TBL] [Abstract][Full Text] [Related]
12. Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells.
Casella C; Miller DH; Lynch K; Brodsky AS
Gynecol Oncol; 2014 Nov; 135(2):333-41. PubMed ID: 25134999
[TBL] [Abstract][Full Text] [Related]
13. Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-κB in human biliary epithelial cells.
Kim Y; Lee EJ; Jang HK; Kim CH; Kim DG; Han JH; Park SM
J Gastroenterol Hepatol; 2016 Jun; 31(6):1220-8. PubMed ID: 26574150
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells.
Li Y; Xian M; Yang B; Ying M; He Q
Stem Cell Reports; 2017 Jun; 8(6):1617-1629. PubMed ID: 28552603
[TBL] [Abstract][Full Text] [Related]
15. HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.
Al-Haidari AA; Syk I; Thorlacius H
Biochem Biophys Res Commun; 2014 Mar; 446(1):68-72. PubMed ID: 24582560
[TBL] [Abstract][Full Text] [Related]
16. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D
Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
[TBL] [Abstract][Full Text] [Related]
18. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
[No Abstract] [Full Text] [Related]
19. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.
Kochuparambil ST; Al-Husein B; Goc A; Soliman S; Somanath PR
J Pharmacol Exp Ther; 2011 Feb; 336(2):496-505. PubMed ID: 21059805
[TBL] [Abstract][Full Text] [Related]
20. Investigation of simvastatin-induced apoptosis and cell cycle arrest in cancer stem cells of MCF-7.
Afzali M; Vatankhah M; Ostad SN
J Cancer Res Ther; 2016; 12(2):725-30. PubMed ID: 27461641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
